{"id":"W4379281805","doi":"10.1200/jco.2023.41.16_suppl.5047","title":"Concurrent chemo-hormonal therapy of enzalutamide (ENZ) and cabazitaxel (CAB) in patients (Pts) with metastatic castration-resistant prostate cancer (mCRPC): Final analysis of objective response rate (ORR), radiographic progression-free survival (rPFS), and overall survival (OS).","year":2023,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Prostate cancer; Enzalutamide; Cabazitaxel; Internal medicine; Progression-free survival; Confidence interval; Response Evaluation Criteria in Solid Tumors; Chemotherapy; Oncology; Hormonal therapy; Cancer; Progressive disease; Urology; Surgery; Androgen deprivation therapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002261705,0.0005256868,0.001115603,0.0004179376,0.0001890814,0.0004936859,0.0003320616,0.0003666343,0.0006917722],"category_scores_gemma":[0.001688854,0.0002433481,0.001277467,0.0005025398,0.0004264635,0.000318818,0.0003124734,0.0005554177,0.0001363644],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007688415,"about_ca_system_score_gemma":0.000874506,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001166397,"about_ca_topic_score_gemma":0.002866142,"domain_scores_codex":[0.9992257,0.0003647501,0.00007566223,0.0001329878,0.0001252285,0.00007570525],"domain_scores_gemma":[0.9991026,0.0002449776,0.0003021148,0.00008310463,0.00007382863,0.0001933974],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.4042523,0.00630203,0.3892707,0.0009953304,0.005552296,0.0005697508,0.0004232379,0.007511339,0.0260356,0.000171438,0.00107174,0.1578443],"study_design_scores_gemma":[0.0462963,0.2681737,0.6594546,0.0000744213,0.005690836,0.0009828471,0.0001540991,0.005574462,0.009716964,0.0001913503,0.003637657,0.00005284926],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9973591,0.001183603,0.0003166877,0.00004255548,0.000008846375,0.0002941039,0.0004228224,0.00001407467,0.000358215],"genre_scores_gemma":[0.9975272,0.0003084961,0.000675717,0.00005363819,0.00001812829,0.0001650621,0.0009535809,0.000004684962,0.0002936467],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002261705,"threshold_uncertainty_score":0.01196116,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1196285046805787,"score_gpt":0.4608818558589242,"score_spread":0.3412533511783454,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}